What is the current valuation of the point-of-care molecular diagnostics market in Japan?

The market valuation was $234.29 Million in 2024. Read More

What is the projected market size for point-of-care molecular diagnostics in Japan by 2035?

The projected valuation for 2035 is $562.05 Million. Read More

What is the expected CAGR for the Japan point-of-care molecular diagnostics market from 2025 to 2035?

The expected CAGR during the forecast period is 8.28%. Read More

Which companies are the key players in the Japan point-of-care molecular diagnostics market?

Key players include Abbott Laboratories, Roche Diagnostics, Cepheid, Thermo Fisher Scientific, Hologic Inc., Qiagen N.V., BD, and Luminex Corporation. Read More

What is the market valuation for PCR Tests in Japan's point-of-care molecular diagnostics market?

The market valuation for PCR Tests ranges from $50.0 Million to $120.0 Million. Read More

How does the market for infectious diseases compare to genetic testing in Japan's point-of-care molecular diagnostics market?

The market for infectious diseases ranges from $70.0 Million to $170.0 Million, while genetic testing ranges from $50.0 Million to $120.0 Million. Read More

What is the expected market size for outpatient clinics in the Japan point-of-care molecular diagnostics market?

The expected market size for outpatient clinics ranges from $84.29 Million to $192.05 Million. Read More

What is the market valuation for cancer diagnosis applications in Japan's point-of-care molecular diagnostics market?

The market valuation for cancer diagnosis applications ranges from $60.0 Million to $130.0 Million. Read More

Japan Point of Care Molecular Diagnostics Market

Q: What are the main types of tests included in the Japan point-of-care molecular diagnostics market?

Main types include PCR Tests, Nucleic Acid Amplification Tests, Microarray, Next-Generation Sequencing, and Other Genetic Tests. Read More

Q: What technologies are driving the Japan point-of-care molecular diagnostics market?

Key technologies include Isothermal Amplification, Polymerase Chain Reaction, Sanger Sequencing, and CRISPR Technology. Read More

ID: MRFR/MED/49958-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Japan Point-of-care Molecular Diagnostics Market Research Report: Size, Share, Trend Analysis By Product Type (PCR Tests, Nucleic Acid Amplification Tests, Microarray, Next-Generation Sequencing, Other Genetic Tests), By Applications (Infectious Diseases, Genetic Testing, Cancer Diagnosis, Metabolic Disorders), By End-use (Hospitals, Diagnostic Laboratories, Home Care Settings, Outpatient Clinics), and By Technology (Isothermal Amplification, Polymerase Chain Reaction, Sanger Sequencing, CRISPR Technology) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Point of Care Molecular Diagnostics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 PCR Tests
  2. 4.1.2 Nucleic Acid Amplification Tests
  3. 4.1.3 Microarray
  4. 4.1.4 Next-Generation Sequencing
  5. 4.1.5 Other Genetic Tests
2. 4.2 Medical Device, BY Application (USD Million)
  1. 4.2.1 Infectious Diseases
  2. 4.2.2 Genetic Testing
  3. 4.2.3 Cancer Diagnosis
  4. 4.2.4 Metabolic Disorders
3. 4.3 Medical Device, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Home Care Settings
  4. 4.3.4 Outpatient Clinics
4. 4.4 Medical Device, BY Technology (USD Million)
  1. 4.4.1 Isothermal Amplification
  2. 4.4.2 Polymerase Chain Reaction
  3. 4.4.3 Sanger Sequencing
  4. 4.4.4 CRISPR Technology
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cepheid (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Thermo Fisher Scientific (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Hologic Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Qiagen N.V. (NL)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 BD (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Luminex Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY TYPE
3. 6.3 JAPAN MARKET ANALYSIS BY APPLICATION
4. 6.4 JAPAN MARKET ANALYSIS BY END USE
5. 6.5 JAPAN MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

PCR Tests
Nucleic Acid Amplification Tests
Microarray
Next-Generation Sequencing
Other Genetic Tests

Medical Device By Application (USD Million, 2025-2035)

Infectious Diseases
Genetic Testing
Cancer Diagnosis
Metabolic Disorders

Medical Device By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Home Care Settings
Outpatient Clinics

Medical Device By Technology (USD Million, 2025-2035)

Isothermal Amplification
Polymerase Chain Reaction
Sanger Sequencing
CRISPR Technology

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”